Author： Larg Allison Moss John R.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.29, Iss.8, 2011-08, pp. : 653-671
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Cost-of-Illness Studies in Diabetes Mellitus
By Ettaro L.
PharmacoEconomics, Vol. 22, Iss. 3, 2004-01 ,pp. :
Access to resources
Recommend
Cost-of-Illness Studies: A Review of Current Methods
By Akobundu Ebere Ju Jing Blatt Lisa Mullins C. Daniel
PharmacoEconomics, Vol. 24, Iss. 9, 2006-01 ,pp. :
Controlling for comorbidity in cost-of-illness studies may cause bias
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 336, 2001-01 ,pp. :
Cost-of-Illness Studies: Useful for Health Policy?
PharmacoEconomics, Vol. 14, Iss. 2, 1998-08 ,pp. :